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MRIAbstract Aim and objectives: To evaluate the value of diffusion-weighted magnetic resonance
imaging (DWI) in localization of diseased bowel segment and to determine the value of apparent
diffusion coefficient (ADC) to diagnose activity in patients with Crohn’s disease.
Materials and methods: 30 patients of Crohn’s disease and 45 normal persons as a control under-
went DWI and ADC maps and the results were compared to the postendoscopic and pathologic
post-operative results.
Results: On DWI bowel segments with active inflammation revealed higher signal compared to
inactive and normal segments. Using ADC, statistical high significance was found between both
active and inactive segment values when correlated to normal segment values with P< 0.05.
Correlating mean ADC value and range of active and inactive segments, a statistical difference
was noted (P< 0.05). Using 1.65  103 mm2 s1 as the cutoff point, the sensitivity of ADC values
for differentiating active and inactive bowels was 88.7%, and the specificity was 80%, PPV 89.7%,
NPV 79.0%, Kappa 0.65 and P< 0.05.
Conclusion: Adding DWI and quantitative ADC value study to MRI imaging is a promising tech-
nique for the detection of inflammation in patients with Crohn’s disease and differentiating between
active and inactive diseased bowel segments.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Crohn’s disease (CD) is characterized by chronic inflammation
with a relapsing and remitting history. Treatment is generally
effective in relieving clinical symptoms. However, preliminaryevidence has suggested that therapeutic strategy for endoscopic
remission might be associated with better outcome. Mucosal
healing (MH) or deep remission emerges as the therapeutic
endpoint in patients with CD, especially in severe or compli-
cated cases. Therefore, monitoring the disease with endoscopy
and cross-sectional imaging is proposed to assess mucosal
healing. Endoscopy allows direct visualization of the mucosa
and acquisition of biopsies. In CD, although endoscopy is an
invasive procedure and expensive in some countries, it is nearly
Table 1 Relation of signal changes in DWI and ADC map
and activity of the lesion.
Active (30) Inactive (15) X2 P
ADC map ADC map 19.45 0.000
Hyperintense
(N= 0)
0.00 Hyperintense
(N= 8)
53.3%
Hypointense
(n= 30)
100% Hypointense
(N= 7)
46.7%
DWI DWI 5.18 0.02
Hyperintense
(N= 24)
80% Hyperintense
(N= 7)
46.7%
Hypointense
(N= 6)
20% Hypointense
(N= 8)
53.3%
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lesions (1). For small bowel CD, the advent of capsule endo-
scopy has improved our understanding of the lining of the
small bowel. However, capsule endoscopy also shows some
limitations. The focal length of the vision is too short to mea-
sure the size of lesions reliably. However capsule endoscopy is
not possible in stricturing disease; hence, radiological imaging
is usually required (2). The use of small bowel MRI is estab-
lished as a diagnostic and prognostic tool in the management
of patients with small bowel Crohn’s disease (3). Currently,
evaluation of the bowel wall by MR imaging is based on its sig-
nal on T2-weighted images, thickness, and the degree of con-
trast enhancement (4). However accurate estimation of the
extent of disease, reliable differentiation between chronic and
active inflammation, and monitoring response to treatment,
remain as diagnostic challenges. Diffusion-weighted imaging
(DWI) is a functional study that reflects the changes in the
water mobility caused by interactions with cell membranes,
macromolecules, and alterations of the tissue environment.
DWI has been widely used for intracranial diseases but has
only recently been applied to the abdomen (5,6). DWI with
parallel imaging allows the detection of inflammation in
patients with Crohn’s disease and ADC values are decreased
in the inflamed bowel segments, indicating restricted diffusion
(7).
2. Material and methods
2.1. Patients
This research was conducted with institutional review board
(IRB) approval and with the waiver of informed consent due
to the retrospective study design and was in compliance with
the Health Insurance Portability and Accountability Act.
The study was conducted from January 2012 to March 2015.
The study included a total of 30 patients of Crohn’s disease.
Selected patients must have the following: 1. recent magnetic
resonance enterography (MRE) and 2. pathological result
proving diagnoses of Crohn’s disease and state of activity.
Pathological assessments as a gold standard evaluation were
acquired through fibro-optic endoscopy in 18 patients, 5 cases
post-surgical resection and 7 patients with capsule endoscopy.
Another 45 normal small bowel segments were used as stan-
dard for comparison.
2.2. MR protocol
MR imaging was performed on a 1.5 T body scanner (Avanto;
Siemens, Erlangen, Germany) with a 33 mT/m maximum gra-
dient capability using a phased-array body coil. Before diffu-
sion weighted imaging was performed, transverse and
coronal T2-weighted half-Fourier single-shot turbo spin-echo
(HASTE) images were acquired during a breath-hold, with
the following parameters: repetition time/echo time (TR/TE),
1000/90–100 ms; slice thickness/slice interval, 8–10/0.
8–1.0 mm in transverse and 5/0.5 mm in coronal view; field
of view, 32–35 cm; matrix, 256  256; and bandwidth,
180 Hz/pixel. In transverse imaging, 25–30 sections were
acquired during a breath-hold of 25–30 s. In coronal imaging,
20–25 sections were acquired during a breath-hold of 20–25 s
and then diffusion weighted single-shot spin-echoecho-planar sequence with the chemical shift selective fat-
suppression technique TR/TE = 7006/86; section thickness 6
mm; intersection gap 1 mm; matrix size 128  128; FOV
360  360 mm; partial Fourier factor 6/8; band width 1158, five
excitations. b values used were b0, b400, b800 s/mm.
2.3. Image analysis
Two radiologists independently, reviewed the MR examina-
tions. The ADC values were calculated by two independent
radiologists in separate sessions. The ADC values were calcu-
lated from the wall of the terminal ileum and normal-
appearing ileal loop (as detected in conventional MRI analy-
sis). To measure ADC values an oval shaped regions of interest
(ROIs) are made on each pathological site. Care was taken to
exclude vessels and motion artifacts from the ROIs. For each
ADC value measurement we applied 3 ROI measurements and
accepted the average of the 3 measurements. Because two
ADC values were obtained (one by each radiologist) for each
segment, the mean ADC was defined as the ADC for each
segment. The reports of endoscopic examinations, surgical
procedures and pathology results were reviewed by a third
radiologist who was not involved in the image analysis. Qual-
itative and quantitative DWI data were analyzed in relation to
pathological data. Sensitivity and specificity were calculated.
3. Result
The current study included a total of 45 segments that were
evaluated as diseased by endoscopy or surgery. The study
included 30 segments of active CD and 15 segments of Inactive
lesions. 30 bowel segments demonstrated active inflammation
and 15 cases showed pathological changes with no active
inflammation. Positive segments were 18 terminal ileum seg-
ments (Fig. 3), 14 distal ileum segments, 10 proximal ileum seg-
ments and 3 cecum segments (Fig. 4).
Active and inactive lesions were determined according to
MRE signs and correlated with pathological diagnosis. Visual
assessment of DWI signal changes and ADC map signal was
compared in active and inactive (Fig. 5) segments (Table 1).
Hypointensity of ADC map was found to be statistically
highly significant in differentiating active from inactive lesions
(P< 0.05). Hyperintense (bright signal) in DWI was statisti-
cally significant, and it shows a lesser P value (P= 0.02) which
remains (P< 0.05). Visual assessment had a sensitivity of
Table 3 Validity of ADC value for differentiating active
lesions from normal areas.
Active
(N= 30)
Normal
(N= 30)
Total
(N= 60)
Kappa P
ADC 6 1.95 30 5 35 0.83 0.000
ADC> 1.95 0 25 25
Sensitivity = 100.0%, Specificity = 83.3%, PPV = 85.7%,
NPV= 100.0%.
Fig. 1 (AUC): validity of ADC value for differentiating active
lesions from normal areas. AUC: 0.98 (0.95–1.0) confidence
interval (CI), Cutoff value = 1.95.
Table 4 Validity of ADC value for differentiating inactive
from normal.
Inactive (N= 15) Normal (N= 30) Kappa P
ADC 6 2.4 15 0 1.0 0.000
ADC> 2.4 0 30
Sensitivity = 100.0%, Specificity = 100.0%, PPV = 100.0%,
NPV= 100.0%.
Table 5 Mean ADC value in relation to the activity.
Role of quantitative MRI diffusion-weighted imaging 5580%, specificity 53.3%, PPV = 77.4 and NPV= 57.1. Quan-
titative analysis of the Mean ± s.d. of ADC value  103
mm2 s1 of the normal small bowel segment wall, active lesions
and inactive lesions was calculated. A statistical high
significance was found with P< 0.05 in both active and inac-
tive segment values when correlated to normal segment values.
The mean ADC value of 30 cases of active bowel segments was
1.36 ± 0.22  103 mm2 s1, compared to normal 2.51
± 0.53  103 mm2 s1 with statistical significance (P< 0.05)
(Table 2). A cutoff ADC value of 1.95  103 mm2 s1 was
calculated and number of active and normal cases in relation
to this value is shown in Table 3. The area under the
receiver-operating characteristic (ROC) curve (Fig. 1) was
0.98 (0.95–1.0) confidence interval (CI) (0.95–1.0). Using
1.95  103 mm2 s1 as the cutoff point, the sensitivity of
ADC values for detecting inflamed bowels was 100%, and
the specificity was 83.3%, PPV 85.7%, NPV 100%, Kappa
0.83 and P 0.000 (Fig. 1). The mean ADC value of 15 cases
of inactive bowel segments was 1.77 ± 0.19  103 mm2/s
compared to normal cases (3.26 ± 0.33  103 mm2 s1) with
statistically significant P value (P< 0.05) (Table 2). A cutoff
ADC value of 2.4  103 mm2 s1 was calculated and number
of inactive and normal cases in relation to this value is shown
in Table 4. The area under the ROC curve was AUC: 1.0
(1.0–1.0) confidence interval (CI). Using 2.4  103 mm2 s1
as the cutoff point, the sensitivity of ADC values for detecting
inactive bowels was 100%, and the specificity was 100%, PPV
100%, NPV 100%, Kappa 1.0 and P 0.000. Correlating mean
ADC value and range of active and inactive segments a statis-
tical difference was noted (P< 0.05) (Table 5). A cutoff ADC
value of 1.65  103 mm2 s1 was calculated and number of
inactive and active cases in relation to this value is shown in
Table 6. The area under the ROC curve (Fig. 2) was AUC:
0.95 (0.88–0.98) confidence interval (CI). Using 1.65  103
mm2 s1 as the cutoff point, the sensitivity of ADC values
for differentiating active and inactive bowels was 86.7%, and
the specificity was 80%, PPV 89.7%, NPV 79.0%, Kappa
0.65 and P 0.000 (Table 6).
4. Discussion
In cases of inflammatory bowel disease it is important to assess
activity of bowel lesions to help the clinician to plan for treat-
ment. The use of MR enterography is established as a diagnos-
tic and prognostic tool in the management of patients with
small bowel Crohn’s disease (3). Diffusion weighted MRI is
a new sequence of MRI which has a high resolution of contrast
that allows differentiating inflamed bowel segments from nor-
mal bowel (7). In our study, depending on visual assessment ofTable 2 Mean ADC value of active and inactive segments in
relation to normal segments.
ADC value ± D (mm2 s1) Paired t P
Active 11.3 0.000
Diseased (N= 30) 1.36 ± 0.22  103
Normal (N= 30) 2.51 ± 0.53  103
Inactive 13.2 0.000
Diseased (15) 1.77 ± 0.19  103
Normal (15) 3.26 ± 0.33  103
Active Inactive t P
N= 30 N= 15
ADC value ± SD 1.36 ± 0.22 1.77 ± 0.19 5.91 0.000
ADC range 1.1–1.9 1.4–2.0DWI and ADC map images, the study showed that abnormal
bowel segments (both active and inactive) can be differentiated
in patients with CD from normal bowel loops. Visual assess-
ment had a sensitivity of 80% and specificity of 53.3% respec-
tively in detection of pathological small bowel segments. Kiryu
Table 6 Validity of ADC in differentiating active from
inactive lesions.
Active
(N= 30)
Inactive
(N= 15)
Total Kappa P
ADC 6 1.65 26 3 29 0.65 0.000
ADC> 1.65 4 12 16
Sensitivity = 86.7%, Specificity = 80%, PPV = 89.7%,
NPV= 75%. Kappa 0.65 and P 0.000.
Fig. 2 (AUC): validity of ADC value for differentiating inactive
lesions from active lesion. AUC: 0.95 (0.88–0.98) confidence
interval (CI), Cutoff value = 1.65.
56 H.I. Tantawy, A.M.W. Algeballyet al. (8), study had a sensitivity and specificity for the visual
assessment of disease-active segments of 86% and 81.4%,
respectively which are relatively higher than those of our
study. This can be due to the fact that in our study we included
both active and inactive segments together to be differentiated
from normal bowel as pathological segments which caused
reduction of the specificity suggesting the need to do qualita-
tive measurement so we can locate both pathological types
(active and inactive diseased segments). In cases of active
Crohn’s disease (CD) due to the high viscosity and cellularityFig. 3 18 year old patient with active Crohn’s disease. (a) DWI shows restriction of terminal ileum segment. (b) ADC map shows
reduced signal of inflamed ileal loop segment. (c) Postcontrast T1WI with FS shows enhanced segment.
Fig. 4 24 year old male with active Crohn’s disease. (a) Restricted cecal wall with associated abscess and fistula tract. (b) ADC map with
low signal of cecal wall. (c) Postcontrast image in T1WI with FS shows pathological wall enhancement of cecum, abscess and fistula tract.
Role of quantitative MRI diffusion-weighted imaging 57of inflamed tissue the extracellular space is reduced causing
restriction of the diffusion of water. Using the sensitivity of
MRI to Brownian motion, it is possible to measure the appar-
ent diffusion coefficient (ADC) which is used as a quantitative
parameter called ADC value (9). Normal bowel segments,
disease-active segments and disease-inactive segments
Mean ± s.d. ADC values were calculated. There was
significant statistical difference between Mean ± s.d. ADC
value between normal bowel loop segments and both active
and inactive disease segments with (P< 0.05). Using a
cutoff ADC value (ADC 6 1.95  103 mm2 s1) we had a
Sensitivity = 100.0%, Specificity = 83.3%, PPV = 85.7%,
NPV = 100.0% in differentiation of normal (non-diseased)
segments from diseased-inactive segments. Using a cutoff
ADC value (ADC 6 2.4  103 mm2 s1) we had a
Sensitivity = 100.0%, Specificity = 100.0%, PPV = 100.0%,
NPV = 100.0% in differentiation of normal segments from
disease active segments. This was in agreement with others
(7,9) who stated that ADC values differed significantly
between actively inflamed terminal ileum and normal ileum.
Mean ± s.d. ADC value in the disease-active segments
was 1.36 ± 0.22  103 mm2 s1 with an ADC range of
1.1–1.9  103 mm2 s1. The Mean ± s.d. ADC value in the
disease-inactive segments was 1.77 ± 0.19  103 mm2 s1with an ADC range of 1.4–2.0  103 mm2 s1. ADC value
of active-disease segments was significantly lower than that
in the disease-inactive segment with a statistical difference
noted (P< 0.05). Using a receiver operating characteristic
(ROC) curve, we determined an apparent coefficient of diffu-
sion (ADC) cutoff value (ADC 6 1.65  103 mm2 s1) which
had a Sensitivity = 86.7%, Specificity = 80%, PPV = 89.7%,
NPV = 75% which indicates that ADC value difference is
feasible method to be used to differentiate active and
inactive segments of bowel loops in cases of CD. Other
researchers had similar results. Kiryu et al. (8), stated that in
the quantitative assessment, the ADC value in the
disease-active area was lower than that in disease-inactive area
in small and large bowels (1.61 ± 0.44  103 mm2 s1 versus
2.56 ± 0.51  103 mm2 s1). Hordonneau et al. (10), stated
that comparing ADC value with contrast enhanced MRE
using a receiver operating characteristic (ROC) curve, they
determined an apparent coefficient of diffusion (ADC)
threshold of 1.9  103 mm2 s1 that yielded a sensitivity
and a specificity in discriminating disease-active from
disease-nonactive CD of 85.9% and 81.6%, respectively, for
the ileum. In our study the ADC values were controlled by
pathology result of activity where we had a slightly lower
cutoff value (ADC 6 1.65  103 mm2 s1).
Fig. 5 Case 3: (a) 28 year old male with inactive Crohn’s disease. (a) DWI shows no significant restriction of pathological segment. (b)
ADC map shows mixed hyper and hypointense segments of bowel wall. (c) No significant enhancement in postcontrast T1WI with FS.
58 H.I. Tantawy, A.M.W. Algebally5. Conclusion
DWI is an important addition to routine MRE examination of
patients with CD. The Visual assessment with DWI allows the
determination of diseased region, and ADC quantitative
analysis may aid the monitoring of disease conditions and
therapeutic effects, and can be used in long-term follow-up
and in cases where Gadolinium cannot be used. DWI is
promising technique which deserves further investigation.Conﬂict of interest
The authors declare that there is no conflict of interest.
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